These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32425687)

  • 1. Understanding the early host immune response against
    Jee B
    Cent Eur J Immunol; 2020; 45(1):99-103. PubMed ID: 32425687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic-and-Epigenetic Interspecies Networks for Cross-Talk Mechanisms in Human Macrophages and Dendritic Cells during MTB Infection.
    Li CW; Lee YL; Chen BS
    Front Cell Infect Microbiol; 2016; 6():124. PubMed ID: 27803888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity in tuberculosis: host defense vs pathogen evasion.
    Liu CH; Liu H; Ge B
    Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoarabinomannan, and its related glycolipids, induce divergent and opposing immune responses to Mycobacterium tuberculosis depending on structural diversity and experimental variations.
    Källenius G; Correia-Neves M; Buteme H; Hamasur B; Svenson SB
    Tuberculosis (Edinb); 2016 Jan; 96():120-30. PubMed ID: 26586646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of mycobacterial survival in macrophages.
    Awuh JA; Flo TH
    Cell Mol Life Sci; 2017 May; 74(9):1625-1648. PubMed ID: 27866220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host defense mechanisms against Mycobacterium tuberculosis.
    Chai Q; Lu Z; Liu CH
    Cell Mol Life Sci; 2020 May; 77(10):1859-1878. PubMed ID: 31720742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Metabolic Regulation Between Host and Pathogens: New Opportunities for the Development of Improved Therapeutic Strategies Against
    Park JH; Shim D; Kim KES; Lee W; Shin SJ
    Front Cell Infect Microbiol; 2021; 11():635335. PubMed ID: 33796480
    [No Abstract]   [Full Text] [Related]  

  • 9. IFN-β: A Contentious Player in Host-Pathogen Interaction in Tuberculosis.
    Sabir N; Hussain T; Shah SZA; Zhao D; Zhou X
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29258190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulation and exploitation of host immune system by pathogenic
    Mir MA; Mir B; Kumawat M; Alkhanani M; Jan U
    Future Microbiol; 2022 Sep; 17():1171-1198. PubMed ID: 35924958
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune Response to
    de Martino M; Lodi L; Galli L; Chiappini E
    Front Pediatr; 2019; 7():350. PubMed ID: 31508399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics of
    Hoffmann E; Machelart A; Song OR; Brodin P
    Front Immunol; 2018; 9():86. PubMed ID: 29441067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus.
    Stamm CE; Collins AC; Shiloh MU
    Immunol Rev; 2015 Mar; 264(1):204-19. PubMed ID: 25703561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunometabolism of Phagocytes During
    Kumar R; Singh P; Kolloli A; Shi L; Bushkin Y; Tyagi S; Subbian S
    Front Mol Biosci; 2019; 6():105. PubMed ID: 31681793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxygen Modulates the Effectiveness of Granuloma Mediated Host Response to Mycobacterium tuberculosis: A Multiscale Computational Biology Approach.
    Sershen CL; Plimpton SJ; May EE
    Front Cell Infect Microbiol; 2016; 6():6. PubMed ID: 26913242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 in host defense against Mycobacterium tuberculosis: to be or not to be-that is the question.
    Gopalakrishnan A; Salgame P
    Curr Opin Immunol; 2016 Oct; 42():76-82. PubMed ID: 27326654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy as an innate defense against mycobacteria.
    Jo EK
    Pathog Dis; 2013 Mar; 67(2):108-18. PubMed ID: 23620156
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Woo M; Wood C; Kwon D; Park KP; Fejer G; Delorme V
    Front Immunol; 2018; 9():438. PubMed ID: 29593716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of toll-like receptor 2 in survival strategies of Mycobacterium tuberculosis in macrophage phagosomes.
    Yoshida A; Inagawa H; Kohchi C; Nishizawa T; Soma G
    Anticancer Res; 2009 Mar; 29(3):907-10. PubMed ID: 19414326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.